Registration under way for CARTI Tour de Rock

Rider registration is currently underway for the 15th annual CARTI Tour de Rock, a cycling-based fundraiser benefiting CARTI cancer patients, scheduled for June 2 at North Shore River Walk, 140 Riverfront Dr.,in North Little Rock.

Presented by Russell Chevrolet and Arkansas’ Best Chevy Dealers, the CARTI Tour de Rock is an open-course ride departing from North Little Rock and routed through Scott and England that annually attracts more than 1,000 cycling enthusiasts from across the United States.

The rides offer cyclists of all abilities route options of 25, 50, 62, 80 or 100 miles. Complete route details and maps are available at CARTI.com.

Routes depart as follows: 100 and 80 mile – 6:30 a.m.; 62 mile – 6:45 a.m.; 50 mile – 7 a.m.; 25 mile – 7:15 a.m.

Registration is $55 per rider through Friday, June 1, or $60 on the day of the event. Riders will receive entry into the ride, an event t-shirt, and post-ride lunch and beer garden access at the finish line. Guests of riders and members of the community who are not riding can participate in the post-ride lunch and beer garden for $25 and will receive an event t-shirt as part of their registration. Lunch is served from 10 a.m. to 3 p.m.

CARTI is in year two of the “I am riding for” campaign, and Tour de Rock provides an excellent opportunity to connect its mission to the community. Every rider receives an “I am riding for” bib and is encouraged to dedicate their ride to someone who has fought cancer. CARTI’s Tour de Rock Facebook page shows many photos of people who proudly wear their bibs during the ride.

Rider registration packets will be available for advance pick up through May 31 (11 a.m. to 6 p.m.) at Russell Chevrolet, located at 6100 Landers Road in North Little Rock, or on June 1 (7 a.m. to 7 p.m.) or June 2 (6 to 7 a.m.) at The Riverhouse on 140 Riverfront Dr. in North Little Rock.

To register, or for more information, contact the CARTI Foundation at 501.296.3406 or visit CARTI.com. All proceeds benefit CARTI and the cancer patients of Arkansas.